Dyslipidaemia in persons with type 2 diabetes mellitus in Kaduna, Nigeria

International Journal of Diabetes and Metabolism

Volumn 15, Issue 1, 2007, Pages 9-13

  Bello Sani, F ^a   Bakari, A G ^a   Anumah, F E ^a  

^a AHMADU BELLO UNIVERSITY   (Nigeria)

Author keywords

Diabetes mellitus; Dyslipidaemia; Ischaemic heart disease

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DYSLIPIDEMIA; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY HOSPITAL; WAIST HIP RATIO;

EID: 40649113970     PISSN: 16067754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. World Health Organization. Report of WHO study group. WHO Technical Report Series 1985; No 727.
2. Alberti KGMM. Diabetic ccidosis, hyperosmolar coma, and lactic acidosis. In: Becker KL. (ed) Principles and Practice of Endocrinology and Metabolism, 2nd Edition Philadelphia; JB Lippincott (publishers) 1995:PP1316-1327.
3. Reaven GM, Bernstein R, Davis B, Olefsky JM. Non-ketotic diabetes mellitus; insulin deficiency or insulin resistance? Am J Med 1976; 60:80-88.
4. Lebowitz HE. Clinician's manual on insulin resistance. Science Press Ltd, 34-42 Cleveland Street, London W1T 4LB, UK, PP 1-67.
5. Hennes MM, O'Shaughnessy IM, Kelly TM et al. Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Hypertension 1996; 28:120-126.
6. Barker DJP, Hales CN, Fall C, et al. Type 2 diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1998; 36: 62-67.
7. Libby P, Aikawa M, New insights into plaque stabilization by lipid lowering, Drugs 1998; 56 (suppl. 2):9.
8. Dichtl W, Nilsson L, Goncalves I et al. Very low dense lipoprotein activates nuclear factor-kappa B in endothelial cells. Circ Res 1999; 84:1085-1094
9. Taguchi S, O'numa T, Yamada T. A comparative study of cultured smooth muscle cell proliferation and injury, utilizing glycated low-density lipoproteins with slight oxidation, autoxidation, or extensive oxidation. J Atheroscler Thromb 2000; 7:132-137.
10. Rabini RA, Tesei M, Galeazzi T, Dousset N, Ferreti G, Mazzanti L. Increased susceptibility to peroxidation of VLDL from NIDDM patients: a possible correlation with fatty acid composition. Mol Cell Biochem 1999; 199: 63-67.
11. Despres JP. Health consequences of visceral obesity. Ann Med 2001; 33: 534-541.
12. Rajman I, Kendall MJ, Cramb R, et al. Investigation of low-density lipoprotein sub fractions as coronary risk factors in normotriglyceridaemic men. Atherosclerosis 1996; 125: 231-242.
13. Turnvall P, Karpe F, Carlson LA, Hamsten H. Relationships of LDL sub fractions to angiographycally defined coronary artery disease in young survivors of MI. Atherosclerosis. 1991; 90:67-80.
14. Gibbons GF. Hyperlipidaemia of diabetes. Clin Sci 1988, 71:477-486.
15. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis, Epid, Pathophysiology, and management. Review article. JAMA 2002; 287: 19: 2570-2581.
16. Navab M, Berliner JA, Watson AD et al. The yin and yang of oxidation in the development of the fatty streaks: a review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 1996; 16:831-842.
17. Sniderman AD, Scantlebury T, Cianfione K. Hypertriglyceridaemic hyperpob: the unappreciated atherogenic dyslipidaemia in type 2 diabetes mellitus. Ann Intern Med 2001; 135: 447-459.
18. Gowri MS, Vander Westhuyzen DR, et al. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to the abnormal composition of HDL. Arterioscler Thromb Vasc Biol. 1999; 19:2226-2233.
19. Resnick HE, Shor RI, Kuller L, et al. Prevalence and clinical implications of American Diabetes Association-defined diabetes and other categories of glucose deregulation in older adults. J Clin Epiderniol 2001; 54:869-876.
20. Adesuyi A Leslie Ajayi. DIASPOA-MEDICINE A handbook of rapid bedside examination and pathophysiology 1995.Jamshid A, Behzad A, Jamshid S. Angina Pectoris: Article-E Medicine Journal 2002; 3:7:1-24
21. Adesanya CO, Nirodi NS. Fatal coronary atherosclerotic heart disease in a Nigerian. Case report with necropsy findings. Diabetes Care 1977; October: PP219-222.
22. World Health Organization (WHO): Diagnostic and classification of diabetes mellitus and its complications: Report of WHO consultation. WHO: Geneva 1999.
23. Trinder P. Determination of glucose-oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6:24-27.
24. ADA: Diagnosis of diabetes mellitus. Detection and management of disorders in diabetes. Diabetes Care 1993; 16: (suppl 2): 106-12.
25. Stadman TC. Methods in enzymology, Vol III Colowick SP, and Caplan NO (eds), Academy press. New York NY.1957,PP 392-394, 678-681.
26. Eschwe'ge E. The dysmetabolic syndrome, insulin resistance, and increase in cardiovascular mortality and morbidity in type 2 diabetes: etiological factors in the development of cardiovascular complications. Diabetes Metab 2003; 29:6519-6527.
27. Dagogo-Jack S, Intensive Life-style Intervention. Research group. US Diabetes Prevention Program. (US DPP) Diabetes Care 2003, 26, 36-47.
28. Zimmet P, McCarty D: The NIDDM Epidemic: Global estimates and projections- a look into the crystal ball. International Diabetes Federal Bulletin 1995; 40:8-16
29. WHO Monitoring Project: a, worldwide monitoring system for cardiovascular diseases. World Health statistics Ann, WHO Geneva 2001.
30. Walinjom FTM. Cadiovascular disorders in Africa. World Health Statistics Quarterly 1993; 46:125-13 3
31. Dagogo-Jack S, Odia OJ. Myocardial infarction in Nigerian Africans. Orient J Med 1990; 2: 129-132.
32. Danbauchi SS, Onyemelukwe GC. Ischaemic Heart Disease in Nigerians. Report of two cases. Diabetes International 2001;10:59-60.
33. Onyemelukwe GC, Stafford WL. Serum lipids in Nigerians: the effect of diabetes mellitus. Trop Geogr Med 1981; 33:323-328.
34. Qureshi BH, Uddin I. Dyslipidaemia and diabetes in Al-Qassim region, Saudi Arabia. Diabetes International 2000; 10:1
35. Fasanmade OA, Okubadejo NU. Clinical profile of Nigerians with diabetes mellitus. African journal of Endocrinology and Metabolism.2003; 4:1:95
36. Onyemelukwe GC, Bakari AG: Pattern diabetes mellitus in the savannah North of Nigeria. ABUMED. 1998; 6:14-18.
37. Bakari AG. Plasma insulin pattern in a Hausa-Fulani ethnic group in northern Nigeria. Ann African Med 2004; 3: 7-9.
38. Marshall J. Bessesen DH, Hamman RF. High saturated fat and low starch and fiber are associated with hyperinsulinaemia in a non-diabetic population. The San Luis Valley Diabetes Study. Diabetologia 1997; 40; 430-434.
39. Defronzo RA, Ferranini F, Koivisto F. New concepts in the pathogenesis and treatment of non-insulin dependant diabetes mellitus. Am J Med 1983; 75: 52-81
40. Bakari AG, Onyemelukwe GC. Insulin secretion in type 2 diabetes: - a review. Diabetes International 2002; 12; 41-43.